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DNA  Rearrangements  Proximal  to  the  EVIl Locus Associated  With  the 
3q21q26 Syndrome 
By ER.  Levy, E. Parganas, K. Morishita, S.  Fichelson,  L. James, D. Oscier, S.  Gisselbrecht, J.N. Ihle, and V.J. Buckle 
Specific  rearrangements  involving  3q21 and 3q26  are well 
documented in acute myeloid  leukemia  (AML). Aberrant 
expression  of  the Ecotropic  virus  integration-l (EVI1) gene, 
located  at 3q26, has  been  reported  in individuals with AML 
and  translocations  or  inversions  of  chromosome  3 long 
arm.  We  have  studied  six  individuals  with  AML  and 
inv(3)(q21q26) for  disruptions to the EVll locus  by in  situ 
hybridization  and  long-range  mapping.  EVll transcripts 
have  been  detected in the blast  cells  of  the two individuals 
HE  OCCURRENCE  in  myelodysplastic  syndromes 
and myeloid leukemias of acquired  abnormalities  of 
chromosome  3 is well documented.’”  Breakpoints involv- 
ing 3q2  1 and 3q26 have been associated with morphologi- 
cally abnormal megakaryocytes, elevated or normal platelet 
counts, and a  poor  prognosis. Minimal or no response to 
chemotherapy  has  been  reported  by  several   group^.^ 
Structural  abnormalities  take  the form of intrachromoso- 
mal  inversions,  inv(3)(q2  lq26),  and  interchromosomal 
rearrangements either between the chromosome  3  homo- 
logues,  eg,  t(3;3)(q2 1;q26), or between 3q2 1 or 3q26 and 
other chromosomes.’ Molecular studies on genes located at 
or near the  chromosomal  breakpoints  may define events in- 
volved in the malignant  transformation. 
One of the  most  common transforming events associated 
with retroviral-induced myeloid leukemias in mice is acti- 
vation  of expression of  the Ecotropic  virus integration-l 
(EVII) gene by retroviral insertions immediately 5‘ of the 
gene or in  a common site of integration (Cb-I/Fim-3)  that 
is 90 kb S’ofthe  gene.4-6  The EVI 1 gene encodes a  zinc  finger 
protein that contains an  amino  terminal domain of 7 fingers 
and a carboxyl domain of 3  fingers4  The EVI 1 protein has 
been shown to be localized in  the  nucleus and  to  bind DNA 
with sequence ~pecificity.”~  The  EVIl  gene is not normally 
expressed in hematopoietic cells but rather shows a spatially 
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available  for  expression  studies.  We derived  a  YAC con- 
taining the EVll gene  and  showed  that it crossed the 3q26 
inversion  breakpoints  in  three  of  four  cases  examined. 
Pulsed field analysis detected aberrant fragments 3 of the 
EVll gene in all six patients. The orientation  of the gene 
was established  and  the locations  of  the breakpoints  were 
refined by in  situ  hybridization  using  phage  clones  from  this 
region. 
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and  temporally  restricted  pattern  of  expression  during 
embryogenesis, suggesting that it may be an  important reg- 
ulatory protein  in morphogenesis.”  Inappropriate expres- 
sion ofthe EVI 1 gene in myeloid cell lines that  are  capable of 
differentiation to granulocytes in response to granulocyte- 
specific colony-stimulating factor  (G-CSF) blocks differen- 
tiation of these cells.” 
The  human  EVII  gene  has  been  cloned  and  shown 
to  map  to  the  region  3q25-q26.2.I2  In  recent  studies 
inappropriate expression of the EVI 1 gene was detected in 
cases  of  AML  containing  inversions  of  chromosome 
3,  inv(3)(q21q26),13 translocations  of  chromosome  3, 
t(3;3)(q2  1;q26),l3.l4  or an insertion involving chromosome 
3, ins(3)(q2  lq25q27).14  In the cases involving translocations 
or insertions,  rearrangements were shown to occur  over 
considerable distances both Sand  3’ of the gene. In the  stud- 
ies reported here, a collection of  six patients with AML and 
inv(3)(q21q26) was examined.  Two  of these  individuals, 
who could be tested for expression, had detectable levels  of 
EVI 1 transcripts in their leukemic blasts. All  six  cases con- 
tained DNA rearrangements  in  a  400-kb region distal to  the 
EVI 1 locus that were detectable by pulsed-field mapping or 
by fluorescent in situ hybridization (FISH). 
MATERIALS AND METHODS 
Cytogenetics 
Five cases ofacute myeloid leukemia  (AML)  with inv(3)(q2 lq26) 
were referred from regional cytogenetics laboratories in the  United 
Kingdom. Fresh peripheral blood and bone  marrow samples were 
cultured in medium  without  mitogen for cytogenetic and in situ 
analysis by conventional techniques. Cultures were synchronized 
with thymidine or 5-Bromo-2”deoxyuridine (Budr) to obtain long 
chromosomes and in the case of Budr, to generate a replication 
banding  pattern. Peripheral blood lymphocytes from control indi- 
viduals were stimulated with phytohemagglutinin,  cultured for 72 
hours, and harvested as for the  patient samples. Cytogenetic analy- 
sis was not performed on  one additional  sample  (Pt6) as  this  has 
been reported previously as  patient  FIL in Fichelson et al.” 
RNA Extraction 
RNAzol” and analyzed as described in Morishita et aI.l4 
Isolation of  YAC Clones 
The following oligonucleotide pair  5’ GTCTTACCTTTCCAA- 
CAGCT 3’ (sense) and 5’ TGCCTTCAAAATATCCGTG 3’ (anti- 
sense) was designed to amplify a 200-bp human DNA fragment 
RNA from blast cells of  patient  5 was extracted by treatment with 
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Fig 1.  Restriction maps of the EVll locus  us- 
ing  data  from  Morishita et  Ss, BssHII; Nr. Nnr 
I; MI, Mlu I; Na, Nar I;  H, Hindlll. (A)  Pulsed-field 
restriction  sites  around  a 1,900-kb region. (B) Re- 
striction  map  around  the  EVll  locus detailing 
probes  used  in  the characterization  of  YAC  clones 
and  patient DNA. Boxes 1  through 6 indicate  ex- 
ons as described  by  Morishita  et al.'.  HZ, 2-kb 
Hindlll fragment  encompassing  the  CpG  island; 
P2, 350-bp HMlIl-BssHll fragment  in the 5 re- 
gion of the CpG  island; Evil  cDNA, 2.4-kb cDNA 
encoding the 3 region  of the gene  mapping 3 to 
the CpG  island. A1  7.2, phage  clone  spanning  ex- 
ons 1  and 2; A3.  phage  clone  containing  the  last 
coding  exon of the EVll gene  and  approximately 
10  kb of genomic  DNA  that is 3 to this  exon. 
B 
6' 
from the third exon (bp 836 to 2,192)  of the human EVIl gene16 
avoiding  cross  homology  with  other zinc finger  proteins. A 3.5-ge- 
nome equivalent YAC library  from a 48,XXXX lymphoblastoid 
was screened by  polymerase chain reaction (PCR) as de- 
scribed  in  Anand et al.19  Three positive colonies were detected, of 
which one, 14EE  12, was purified and characterized. 
Probes 
The EVI 1 locus has  been well characterized by Morishita et al.14 
There is a CpG island in the 5'  region  of the EVI 1 gene containing 
sites  for  BssHI1, Mlu I, Nar  I, and Nru I rare cutting restriction 
enzymes.  These  sites  are encompassed  within a 2-kb HindIII frag- 
ment. The Fim-3/Cb-l  viral integration region  is  90  kb 5'  to the 
EVI 1 locus6  (Fig 1 A). 
YAC characterization.  Three probes  from  the EVI 1 region  were 
used to characterize the YAC clone. Fim-3 206PP20  is  a 2-kb 
mouse  genomic  fragment2'  that maps to the Fim-3/Cb-l region. A 
human 2.4-kb EVI 1 cDNAI3  detects regions that are distal to the 
CpG island and would include the  3'  region  of  the EVII  gene. 
Lastly, a 2-kb HindIII genomic fragment  from the 5'  region  of the 
gene,  within  the CpG i~land,'~  was  used (Fig  IB). 
Pulsed-freld  analysis.  Three probes were  used  for pulsed-field 
analysis: Fim-3 206PP20,  P2,  a 350-bp HindIII/BssHII fragment 
from the 5' region ofthe CpG island, and the Evi-I cDNA, mapping 
3' of the CpG island  (Fig  IB). 
FISH.  YAC  14EE12  containing the EVIl gene, X phage  17.2 
spanning the CpG island, X phage 3 containing the last  coding  exon 
of the EVI 1 gene and approximately 10 kb of genomic DNA that is 
3' of this exon (A. Gajjar, E. Parganas, J.N. Ihle, unpublished data, 
December  1993)  (Fig  1  B). 
FISH 
FISH  of  phage  and YAC sequences to normal and patient meta- 
phases were performed as described in Hirst et al?' Hybridization 
mixes containing 20 ng/mL of  YAC  or phage  DNA  with 750  ngl 
mL Cot l DNA  for  YAC and 200 ng/mL Cot 1 DNA for phage  were 
denatured and preannealed for 15 minutes at 37°C. 
Probe was detected  with  successive  layers  of  fluorescein-conju- 
gated  avidin  (Vector,  Peterborough,  UK)  and  biotinylated anti-avi- 
din (Vector). Slides  were  incubated with  Hoescht  33258  (Sigma, 
Poole, UK) (4 mg/mL) for 10 minutes and mounted in antifade 
(Vector) containing propidium iodide (PI)  (1 mg/mL) for  Budr-in- 
corporated metaphases, or mounted in 4,6,diamidino-2  phenylin- 
dole dihydrochloride (DAPI) (2 mglmL) and propidium iodide (l 
mg/mL) to show G banding under ultraviolet  excitation.  Meta- 
phases  were  examined and images  captured on an MRC 600 confo- 
cal  laser  microscope  (Bio-Rad,  Hemel Hempstead, UK). 
DNA Preparation and Restriction Digests for Pulsed-Field 
Gel Electrophoresis 
Human DNA  was isolated  from  peripheral  blood  and bone mar- 
row samples of patients and from  peripheral  blood  of normal indi- 
viduals. 
Because  all  blood  samples  from  AML patients contained more 
than 20%  blasts, no attempt was made to separate cell  types.  Red 
blood  cells  were  lysed  from  whole  blood  and bone  marrow  by incu- 
bation with ammonium chloride lysis  buffer  (NH4CI  [ 150 mmol/ 
L], KHCO, [O. 1 mmol/L], Na'  EDTA  [O. 1 mmol/L] pH  7.3)  at 4'C 
for 20 minutes. Cells  were  pelleted  by centrifugation,  washed  twice 
in phosphate-buffered  saline  (PBS),  and resuspended at 1 X  IO'  or 
2 X  IO7 cells per mL of  PBS.  Cells  were  embedded in low-melting- 
point agarose (Sigma) and processed as described in Harris et 
Blocks  were  washed  five  times in I X TBE  (0.089 mol/L Tris, 0.089 
mol/L borate, 2 mmol/L EDTA) and digested  according  to manu- 
facturer's instructions with  BssHII  or Nar I restriction  enzymes. 
Pulsed-Field Gel Electrophoresis 
Contour  clamped  homogeneous  electric  field  electrophoresis 
(CHEF) gels  were run on the Bio-Rad CHEF DR I1 system at 4°C. 
Pulse times were 40 to 90 seconds or  80 to 200  seconds  separating 
up to 600 kb and  I  Mb,  respectively.  One percent  agarose  gels in 
0.5X TBE  were run for 48 or 64 hours at 150 V or  130  V. Standard 
size markers used  were  yeast  chromosomes  of Saccharomyces  cere- 
visae strain YNN29S and lambda concatamem  (Bio-Rad). 
After  electrophoresis,  gels  were stained in 5  mg/mL ethidium bro- 
mide for 10 minutes, destained  for 20 minutes in dH20,  and UV 
irradiated on a transilluminator for 2 minutes. Gels were denatured 
in 1 mol/L NaOH, 60 minutes, neutralized in 3 mol/LNaCI, 1 mol/ 
L Tris pH 7.5, and transferred to Hybond-N or Nytran in IOX SSC. 1350  LEVY  ET  AL 
Table 1. Karyotypes  and  FAB  Classifications  of  Patient Material 
Patient  Karyotype  Classification 
1  46,XY. inv(3)(q21  q26). iso7(q)  RAEB +  AML M7 
2  46,XY. inv(3)(q21q26)  AML M4 
3  46,XX. inv(3)(q21  q26)x2, t(9; 17;22)  CML +  AML M4 
4  45,XY. -7, inv(3)(q21q26)  Not  available 
5  46,XY. inv(3)(q21q26)  RAEB +  AML M6 
6  46,XX. inv(3)(q21q26)  AML M5 
After  transfer,  DNA was bound to the membrane by UV cross-link- 
ing on  a  stratolinker  (Stratagene,  La Jolla, CA) or baked  at  80'C  for 
2 hours. 
Probes  were  prepared  by  conventional  digestion followed by 
Geneclean (Stratech, Luton, UK) or PCR amplification from M  I3 
primers.23  Inserts  were  nonisotopically labeled  by  random  prime 
incorporation of DIG-l IdUTP  using Boehringer Mannheim pro- 
tocols and reagents. Unincorporated nucleotides were removed by 
spin dialysis on Sephadex  columns (Select-D column; 5'-3'  Inc, 
Boulder,  CO).  Filters  were  hybridized  in  50% formamide, 6X SSC, 
5% dextran sulfate, 1% sodium dodecyl sulfate (SDS),  5X Denhardt, 
and  100  mg/mL sonicated single-stranded salmon sperm  DNA. 
Ten nanograms of insert per milliliter hybridization mix was dena- 
tured and hybridized to  filters  for  18 hours at 43°C. Filters  were 
washed  stringently up to 0.05X SSC, 0.2%  SDS at 65°C and incu- 
bated  with  blocking reagent (4%  nonfat dried  milk  in  antibody 
buffer: 100 mmol/L Tris/ I50 mmol/L NaCl  pH 7.5). After incuba- 
tion with anti-digoxigenin antibody Fab  fragments  conjugated  to 
alkaline phosphatase (35 mU/mL), conjugates were detected by 
chemiluminescent reaction  with  Lumigen PPD (50 pg/mL) (Boeh- 
ringer Mannheim, Mannheim, Germany) at pH 9.5 and exposed to 
Kodak-X-omat AR  film  (Eastman Kodak, Rochester, NY) for 3 
hours. 
RESULTS 
We  studied  six  individuals  with  AML  and  an inv(3Xq2 lq26) 
in their blast  cells.  The karyotypes and French-American- 
British  (FAB)  classifications  are shown in Table 1. All indi- 
viduals  except  patient 2 presented  with  trilineage  dysplasia, 
and FAB  classifications  ranged  from  M4  to M7.  EVI 1 ex- 
pression  was  previously  shown  for  patient 6 (FIL)  by Fichel- 
son et  and as shown  in  Fig  2, EVII transcripts were 
detected by  PCR in  RNA  from  blast  cells  of  patient  5. 
To ascertain the proximity of the EVI 1 gene to the 3q26 
breakpoints, a YAC  containing EVII  sequences  was  iso- 
lated as described and used  for  in  situ  hybridization to pa- 
tient metaphases. The 14EE  12 clone contains a 430-kb  in- 
sert  and  hybridized  to  a  single  site  in  normal  male 
metaphases at 3q26  (Fig  3A).  Further characterization on 
Southern  blots was performed using three probes  from the 
EVI 1 region (Fig 1 B). The YAC clone was found to be  posi- 
tive  for  all three probes (data not  shown)  extending  from  the 
5' Fim-3lCb-l region through the CpG island and into the 
3' sequences  detected  by the EVI 1 cDNA  probe. 
Metaphases  from  patients I, 2, 3, and 5 were  hybridized 
with the 14EE12  YAC  clone.  Patients I, 2, and 5 showed 
signal at both  3q2  I and 3q26 on the inverted  chromosome, 
indicating that the breakpoints  occurred  within  the 430-kb 
region  covered  by the clone  (Fig  3, B through  D).  Patient  3 
has no normal but two  inverted  chromosomes  3.  There was 
no  detectable  signal  at 3q21  on  either inverted  chromo- 
some,  suggesting  that in this  patient  the 3q26  breakpoint 
occurs  proximal to the span of the YAC or at least at the 
very proximal  end  of that span  (Fig  3E).  (Cytogenetic  mate- 
rial  was not  available  for  in situ  analysis  from  patients  4 and 
6.) 
Classical Southern analysis  on  DNA  from  patient  6 has 
been  performed  previ~usly'~  and  showed  no detectable 
DNA  rearrangements in the vicinity  of  the  EVII  gene. 
Southern analysis  on patients 1 through 5 also failed to show 
altered  fragments with two enzymes when  probed  with  the 
EVI 1 cDNA (data not  shown). However, the proximity of 
the breakpoints to the EVI 1 locus was confirmed by pulsed- 
field  analysis.  To identify  rearrangements  5'to the gene,  two 
probes (P2 or Fim-31Cb-  1) were  used  that are both 5' of a 
BssHII  site  in  a CpG  island 5' to the gene. These  probes  de- 
tect a BssHII  fragment  of 610  kb  in  control samples. To 
identify  rearrangements  3'  of  the CpG  island,  the Evi-l 
cDNA  probe  was  used  which detected a BssHII  fragment  of 
940 kb in control samples.  No  novel  fragments  were  de- 
tected  with  the 5'  probe in patients  l, 2, or 3 (data not 
shown). In contrast, all  patient  samples  contained  novel 
BssHII  fragments  ranging  from  240 to 500 kb that were de- 
tectable with  the Evi-l  cDNA  probe  (Fig  4A),  indicating 
that the rearrangements were 3' of the CpG island.  It  should 
be  noted that patient 3 contained  only  an  altered  fragment, 
consistent with the presence of two  inverted  chromosomes 
123 
280 bp - 
253 bp - 
Fig 2.  Expression  of the  EVll gene  in AML blasts  containing  an 
inv(3)(q21q26). RNA was obtained  as  previously des~ribed'~  and 
used to prepare cDNA, which was used  for  PCRs  with oligonucleo- 
tide primers  for  the EVll gene  as  previously  de~cribed.'~  The 5 
primer initiates at base 21  10  and the 3 primer terminates at base 
2390  of the human €vi-l cDNA.''  These  primers  detect an  alterna- 
tively  spliced  transcript  in which 27  bp  is  deleted,  removing  9 amino 
acids  and  leaving  the reading frame intact. The samples  examined 
included:  lane  1, a human  myeloid  leukemia  cell  line  (UCSD/AMLl) 
that contains a t(3;3)(q21;q26)'4; lane 2, patient 5 of this  study: 
and  lane  3, the  HECl  B cell  line  that has  been  shown  to express the 
EVll gene.'' EVll AND THE  3q21q26  SYNDROME  1351 
Fig  3.  FISH  of  Yac  and 
phage  clones.  Fluorescent  sig- 
nals  identifying an inversion on 
chromosome  3 long arm have 
been  marked  with arrows. (A) 
YAC  14EE12  hybridized to  a 
normal  male  metaphase.  (B 
through D)  YAC 14EE12 hybrid- 
ized to patients 1, 2, and 5 re- 
spectively. (E) YAC 14EE12 hy- 
bridized  to patient 3. (F)  A phage 
3 hybridized to patient 1. 
'\  L 
and  no  normal  chromosome  3  (Table  1).  The  re-  This may indicate a change in methylation  status at sites 
arrangements were also detectable with a second enzyme  within the region giving rise to larger size fragments not vis- 
(Nar  I, Fig  4B) and altered fragments were detectable in  the  ible within the range of the gel. 
144- to 432-kb range. No abnormal Nar I fragments were  To narrow  down  the  3q26  breakpoint  region, phage 
detected with the 5' P2 probe (data  not  shown). It is interest-  clones from the EVI 1 region (Fig 1  E) were  used for in situ 
ing to note that the normal allele appears under-represented  hybridization. X Phage 17.2 spanning exons 1 and 2 hybrid- 
in all patient samples, particularly with the BssHII digests.  izes to 3q26 on normal  male metaphases and at 3q26 in 1352 
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Fig 4.  Examples of altered fragments observed in samples  of 
blast  cells  hybridized  with  the NI1  cDNA. (A) BssHll digests of 
DNA samples  from  patients 1 through  5  (patient 6 not  shown)  sep- 
arated with pulse times of 80 to 200 seconds.  A  single  fragment of 
945 kb was observed in DNA from three samples of  peripheral 
blood  from  normal  individuals.  Altered fragments  in  the range  of 
250  to 389  kb  (see  arrows) were observed  in  samples  of  blast  cells. 
(B)  Ner I digests  hybridized with the €VI1 cDNA. Single  fragments 
were observed  in  control  samples  of 388 kb  and  altered fragments 
in the range of 144  to 432  kb were observed (patient 4 not  shown). 
patients 1, 2,  3,  and 5,  confirming that the breakpoints are 
3’to the CpG  island  (data not  shown).  X Phage  P3  is  derived 
from the 3’end  of  the EVI  1 gene and contains the last  coding 
exon and approximately IO kb 3’  of  the gene.  DNA  from 
this phage  hybridizes to 3q26 on normal  male  metaphases 
and again  remained at 3q26 on the inverted  chromosomes 
in patients I, 2,  3, and 5 (an example is  given  in Fig 3F). 
These data support the Southern analysis that failed to de- 
tect  altered  fragments  in any patient with the EVI l cDNA 
and show that the rearrangements do not occur within the 
coding region  of  the gene but rather lie  between  the 3’end  of 
the gene and the Nur I site  (Fig  5). 
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The approximate region spanned by the YAC and the ex- 
tent ofthe breakpoint  regions  in 3q26 asdeduced from  these 
hybridization and pulsed  field  studies  are  summarized  in Fig 
5. These data also  provide  an orientation for the EVI 1 gene 
with  respect to the centromere. The breakpoints have  been 
shown to be localized  3‘ to the EVI 1 gene and sequences at 
the 3’ end of this gene  remain  distal to the 3q26  inversion 
breakpoint, which demonstrates  the order qter-FIM3-EVI  1 - 
cen  (Fig  5). 
DISCUSSION 
Aberrant  expression  of  the EVI  1 gene  has  been  associated 
with AML in both murine, retroviral  models,“  and in hu- 
man~.’~,’~  Our studies  extend  these  observations  by  impli- 
cating the EVI  1 gene in cases  of  AML  with  inv(3)(q2  lq26) 
and show that the breakpoints  occur  3’of  the gene. In previ- 
ous studies,  expression  ofthe EVI 1 gene  was  not  detected  in 
seven  cases  ofAML with inv(3)(q2  Iq26)l4  whereas a second 
study  detected  expression  in two oftwo cases,13  one  ofwhich 
is further studied here.  Although  EVI 1 expression  could  not 
be examined in all  of the cases  studied here, the one addi- 
tional case that could  be  examined  was also  found  to express 
the EVI I gene. The basis  for  the differences  in  EVI  I expres- 
sion are not  known. It  is possible that two  different  types  of 
inv(3) exist, one that involves the EVI1  gene and one that 
does  not. All the cases  described  here  exhibited  a differen- 
tiated  phenotype  (FAB  types M4-M7),  whereas  the inv(3) 
cases  without EVI I  e~pression’~  were immature cell types 
MO-M2.  Whether  the  two  forms  also  involve  re- 
arrangements of  different  regions  of  3q26  has  yet  to be de- 
termined, because  pulse-field  analysis  has  not  been  per- 
formed with leukemic  blasts  from  cases  ofinv(3)  that do not 
express EVI  I. Alternatively, other genetic  alterations may 
be contributing to the phenotype.  Importantly,  all the cases 
that have  been  shown to express the EVI 1 gene contain de- 
tectable  rearrangements  3’ of the gene. 
All the rearrangements  detected  in  the inv(3) cases  exam- 
ined  here  occurred  3’  of the gene and outside  the  coding  re- 
gion.  In  previous  studies  rearrangements  were  found  either 
3’, within, or considerable  distances 5’  of the gene. Thus, 
from the two  studies,  activation  of the EVI 1 gene  has  been 
shown to occur by  disruptions of  DNA  over  a region  of ap- 
proximately 800 kb surrounding the gene. 
The ability of 3’ disruptions to induce  expression  of the 
EVI I  gene  may  be  comparable  with  the  variant  transloca- 
tions in  plasmacytomas  and Burkitt’s lymphomas  described 
by Cory et al,24  Graham and  Adams,”  and Heinglein et 
These  studies have  shown that translocations as far as 260 
kb 3’ of the c-myc  gene  can  alter its  expression  and  contrib- 
ute to leukemogenesis.  In  the case  of  the c-myc  gene,  the 
rearrangements  interfere  with  normal  cessation  of  c-myc 
transcription with differentiation,  whereas  in  the case ofthe 
EVI I  gene the rearrangements may  be  associated  with the 
inappropriate expression of the gene. The mechanisms by 
which these  long-range  effects  are mediated are not  known; 
however,  it  can be  speculated  that the chromosomal re- 
arrangements in both  cases  introduce elements that affect 
chromatin structure in such a way as to affect  regulation  of 
the transcription ofthe genes. EVll  AND  THE  3q21q26 SYNDROME  1353 
Fig 5.  Region  spanned  by  YAC 14EE12: solid 
line  represents  region  known  to be present from 
Southern  Mot  analysis;  dashed  line  represents  ex- 
tra possible  coverage.  Mid  block  denotes  break- 
point  region of patients  ascertained fnnn South- 
ern,  pulsed-field,  and  FISH  analysis.  The  extent  of 
the  breakpoint  regions  are  defined  by  XP3  (pa- 
tients l,  2,3, and 5) or by the 3  end of EVll (pa- 
tients 4 and 6)  and  by  the size of the altered Nar l 
fragment  in  each  patient. 
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In murine model  systems  aberrant expression  is  com- 
monly  associated  with  an inability to terminally differenti- 
ate.  More importantly, the introduction of expression con- 
structs for EVI 1 into a myeloid  cell  line that has the capacity 
to differentiate to granulocytes in  response  to G-CSF blocks 
differentiation."  More recently,  expression  of  the  EVI 1 
gene has been  found to block erythroid differentiation in 
both a myeloid  cell  line and in normal bone marrow pro- 
genitor~.~'  The basis  for  this effect is not known; however, it 
may  be  related  to the DNA-binding properties of the EVI 1 
protein. In particular, the first domain of zinc fingers binds 
the  consensus  sequence  GA(T/C)AAGA(T/C)AAG- 
ATAA8*9  and more recently has been found to bind the ge- 
nomic DNA containing various types of GATA repeats (T. 
Matsugi, B. Kreider, R. Delwel,  J.N.  Ihle:  submitted). Thus, 
the possibility  exists  that  the  EVZI protein binds to GATA- 
containing sequences and  interferes with  transcriptional 
factors  such  as GATA-I, which is required for erythroid 
differentiation.  Alternatively,  transformation  may  be 
caused by increased transcription of other genes that con- 
tain EVI 1 binding sites.* 
Comparison of a number of literature cases of  AML  with 
chromosome 3 abnormalities has confirmed the existence 
of a 3q2 1  q26 syndrome characterized  by normal or elevated 
platelet counts, hyperplasia  with  dysplasia  of megakaryo- 
cytes, multilineage involvement, short duration of any my- 
elodysplastic  phase,  and a poor progn~sis.~  Consistent with 
this, all but one of the patients studied here  had  trilineage 
dysplasia. In the reported cases of 3q2 1  q26 syndrome there 
is a high incidence of accompanying chromosome 7 defects 
and two ofthe six patients examined here had abnormalities 
of chromosome 7. However, the two patients expressing 
EVI 1 in  these  studies did not have abnormalities, suggesting 
that expression  is  independent of the chromosome 7 re- 
arrangements. 
The 3q21q26 syndrome has a cytogenetic  corollary  on 
chromosome  16 where inversions and translocations in- 
volving bands 16pl3  and 16p22 are associated  with  AML 
M4  with eosinophila. Areas of cross  homology  between 
16q22 and two sites on  16p  have  been  identified  and the 
short arm p 13 breakpoint has been shown to be  located 
within a cluster of  repeated  sequences2' It has been sug- 
gested2' that cross-homologies  between  16pl3 and  16q22 
facilitate rearrangements that  may juxtapose  critical se- 
quences and lead to leukemogenesis. Further characteriza- 
tion  of  the  3q21  and  3q26  breakpoints  will  elucidate 
whether this situation may  also  hold true for the chromo- 
some 3 rearrangements. 
;U,  CENTROMERE 
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